Skip to main content
Clinical Trials/NCT00896649
NCT00896649CompletedNot Applicable

Impact of Dedicated Breast Positron Emission Mammography vs. Conventional Two-View Digital Mammography on Recall Rates and Cancer Detection as a Screening Examination in Underserved Women

Boston Medical Center1 site in 1 country193 target enrollmentStarted: February 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
193
Locations
1
Primary Endpoint
Frequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" in Positron Emission Mammography

Study Overview

Brief Summary

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors.

PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.

Detailed Description

OBJECTIVES:

  • To install the breast Positron Emission Mammography system and to test and ensure its compliance with all regulatory agencies including the American College of Radiology and the Food and Drug Administration.
  • To measure and compare the number of call-backs for positron emission mammography (PEM) imaging and conventional mammography.
  • To measure and compare patient satisfaction for both conventional mammography and positron emission mammography in terms of comfort and pain.

OUTLINE: Patients undergo a conventional two-view mammogram and positron emission mammography (PEM). Immediately following treatment, patients complete a questionnaire on their satisfaction with the standard mammogram and the positron emission mammography.

After completion of study treatment, patients are followed annually.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
35 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •DISEASE CHARACTERISTICS:
  • •Scheduled to undergo screening mammogram at one of the Boston Medical Center-affiliated primary care clinics and meets 1 of the following criteria:
  • •Dense breast tissue
  • •At high-risk for breast cancer
  • •PATIENT CHARACTERISTICS:
  • •Has 1 of the following racial or ethnic backgrounds based on the patient's country of birth or the mother and father's country of birth:
  • •Haitian Creole
  • •African American
  • •Caucasian
  • •PRIOR CONCURRENT THERAPY:
  • •None specified

Exclusion Criteria

  • •No history of breast cancer, palpable breast mass, abnormal nipple discharge, or other focal complaints warranting diagnostic mammogram

Arms & Interventions

positron emission mammography

Experimental

questionnaire administration digital mammography positron emission mammography

Intervention: questionnaire administration (Other)

positron emission mammography

Experimental

questionnaire administration digital mammography positron emission mammography

Intervention: digital mammography (Procedure)

positron emission mammography

Experimental

questionnaire administration digital mammography positron emission mammography

Intervention: positron emission mammography (Procedure)

Outcomes

Primary Outcomes

Frequency of Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" Call-back in Mammography vs Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" in Positron Emission Mammography

Time Frame: immediately at completion of mammogram

Number of participants called back due to Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" Mammogram compared to number of patients with Breast Imaging Assessment Reporting and Data System (BI-RADS) "0" in positron emission mammography Breast Imaging Assessment Reporting and Data System (BI-RADS) Scale: 0 = Inconclusive for malignancy; call-back in mammography 1. = normal 2. = abnormal, with no malignancy 3. = abnormal, likely benign 4. = abnormal, likely malignant 5. = malignant

Secondary Outcomes

  • Patient Satisfaction Level as Pertaining to Comfort and Pain for Each Study(One month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gustavo Mercier

BMC Attending Physician

Boston Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Positron Emission Mammography and Standard... | Clinical Trial